Patient-reported pain and impaired sleep quality in adult patients with cystic fibrosis  by Flume, Patrick A. et al.
Journal of Cystic Fibrosis 8 (2009) 321–325
www.elsevier.com/locate/jcfOriginal Article
Patient-reported pain and impaired sleep quality in adult patients
with cystic fibrosis☆
Patrick A. Flume a, b,⁎, Jody Ciolino c, Susan Gray a, Mary K. Lester d
a Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Room 812-CSB, Charleston, SC 29425, United States
b Department of Pediatrics, Medical University of South Carolina, 96 Jonathan Lucas Street, Room 812-CSB, Charleston, SC 29425, United States
c Department of Biometry, Medical University of South Carolina, 96 Jonathan Lucas Street, Room 812-CSB, Charleston, SC 29425, United States
d Department of Respiratory Therapy, Medical University of South Carolina, 96 Jonathan Lucas Street, Room 812-CSB, Charleston, SC 29425, United States
Received 12 May 2009; received in revised form 6 July 2009; accepted 14 July 2009
Available online 8 August 2009Abstract
Background: Sleep impairment has been described in patients with cystic fibrosis (CF). Pain is a known cause of sleep disturbance and as pain is
commonly reported in patients with CF, we sought to find an association between impaired sleep quality and pain.
Methods: Fifty adult CF patients completed surveys of pain and sleep quality. The results were analyzed with additional clinical data including
age, sex, nutritional status, and lung function.
Results: Thirty-two patients (64%) reported recent pain and 33 patients (66%) reported abnormal sleep quality. The patients with pain report worse
sleep quality than those without pain (p=0.006). There was a strong correlation between impaired sleep quality and pain (pb0.0001).
Conclusions:We found that pain and poor sleep quality are reported in a majority of adult CF patients and there is a strong correlation between the
two. This will have important clinical implications in the evaluation and treatment of adult patients.
© 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Pain; Sleep quality; Cystic fibrosis; Adult1. Introduction
Sleep disruption is a common symptom described in patients
with chronic disease and is thought to contribute to impaired
daytime functioning and overall quality of life [1]. Sleep
impairment has been described previously in patients with cystic
fibrosis (CF). Reported sleep complaints have included insomnia,
frequent awakening, and the lack of a good night sleep [2].
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doi:10.1016/j.jcf.2009.07.004worsening of sleep [3]. Patients with more advanced obstructive
disease have greater sleep fragmentation, which is, in turn,
associated with impaired sleep quality [4]. These abnormalities
have been attributed to a number of causes including nocturnal
hypoxemia and hypoventilation, chronic cough, and an adverse
effect of medications, among others [5,6].
There are other well-known causes of sleep disturbance that
may be relevant in patients with CF, such as pain and
depression, which are often reported by patients with CF
[2,7,8]. Similar to the association of impaired sleep quality and
advanced lung disease noted above, there is an association
between pain and the severity of lung disease, with pain
increasing near the end of life [7]. It is notable, however, that
there are reports of considerable pain occurring in younger
patients [9,10]. Given the well-known correlation between pain
and poor sleep quality in other chronic illnesses, [11–13], we
sought to find a similar association between impaired sleep
quality and pain in an adult population of CF patients usingd by Elsevier B.V. All rights reserved.
Fig. 1. Rated severity of pain and its effect on sleep. The BPI asked patients to
describe the severity of pain they experienced in the previous month as well as
rate the degree to which it affected their sleep. Mean values (±SD) are
demonstrated for those patients who reported pain (n=32).
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hypothesis that patients with CF who report pain will also report
impaired sleep quality.
2. Methods
The Institutional Review Board for the Protection of Human
Rights at the Medical University of South Carolina (MUSC)
approved all aspects of this investigation. Patients with CF who
receive their care at the MUSC Adult Cystic Fibrosis Program
were recruited for participation in this study. Patients completed
two validated surveys: a modified Brief Pain Inventory [14] and
the Pittsburgh Sleep Quality Index [15]. Both surveys were
completed at one visit. Additional data collected at that visit
included the patient's age, sex, nutritional status (body mass
index, BMI), and measures of severity of lung disease (i.e.
spirometric measures including the forced vital capacity (FVC)
and the forced expiratory volume at one second (FEV1); these
values were recorded as a percent of predicted).
2.1. Modified brief pain inventory
The Brief Pain Inventory (BPI) is a pain assessment tool
developed for use with cancer patients to measure both pain
intensity and pain interference in the patient's life [14]. We
modified the BPI by adding one question appropriate for CF
patients (i.e. performance of therapies). The instrument asks
patients to report whether they had any pain, aside from minor
daily pains, in the past month, and to rate the severity of the pain
on a scale of 0 (“no pain”) to 10 (“pain as bad as you can
imagine”). The patients were also asked to rate how much their
pain interfered with such things as their enjoyment of life, level of
activity, ability to walk, mood, sleep, work, relations with others,
and performance of their CF therapies. These scales had the
phrases “does not interfere” at the 0 and “interferes completely” at
the 10.
2.2. Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index (PSQI) is a self-rated
questionnaire, which assesses sleep quality and disturbances over
a 1-month time interval [15]. It is a brief, validated instrument that
has been used successfully in a CF population [4,16]. Nineteen
individual items generate seven component scores: subjective
sleep quality, sleep latency, sleep duration, habitual sleep
efficiency, sleep disturbances, use of sleeping medication, and
daytime dysfunction, and the sum of the component scores yields
one global score. The range of possible global scores is 0 (best) to
21 (worst) to measure subjective sleep quality. A global PSQI
score of N5 indicates impaired sleep quality.
2.3. Statistical analyses
Statistical analyses were performed using SAS 9.1 statistical
software and SPSS for Windows 11.5. Descriptive statistics for
variables of interest were calculated and reported. All assump-
tions for statistical analyses were tested where appropriate, andresults were confirmed using nonparametric analyses where
applicable.
The PSQI and BPI each have a question that rates how much
pain interferes with sleep. Aweighted Kappa statistic and a test
for symmetry both suggest that the patient responses to these
questions were concordant.
Independent two sample t-tests were performed to compare
age, BMI, FEV1, FVC, and PSQI global score between pain
groups. A chi-squared test for difference in proportions was
performed for the proportion of patients reporting pain with
abnormal PSQI and normal PSQI scores. Independent, two-
sample t-tests were also performed to assess similarity of possible
confounding variables between the normal and abnormal PSQI
groups.
Spearman's rank correlation coefficient was calculated to
evaluate the association between global PSQI score and rank
(0–10) of how much pain has interfered with sleep in the last
30 days. Patients not responding to this question were given a
rank of zero since they did not report any pain in the last
30 days. A subsequent simple linear regression analysis was
conducted using global PSQI as the outcome variable and
ranking of how much pain has interfered with sleep as the
predictor. Additionally, logistic regression analysis techniques
were used to predict the likelihood of a patient reporting pain
given his or her global PSQI score.
ANOVA and Bonferroni simultaneous comparison techni-
ques were used to compare mean global PSQI score between
groups based on response to how often pain has resulted in
difficulty sleeping. A p-value of less than 0.05 was considered
significant.
3. Results
Fifty adult patients (27 male, 23 female) completed the study.
The mean age was 31.1 years (±8.1) with a range of 18–53 years.
Therewas a wide range of severity of pulmonary impairment with
a mean FVC of 77.4% predicted (SD 18.3, range 39–110) and a
Table 1
Comparison of patients based on reporting of pain.
Pain No pain p 95% Confidence
interval
n 32 18 Pain No pain
Age (y) 30.6±6.5 32.1±10.5 0.574 28.2–32.9 26.9–37.3
BMI 21.3±3.0 21.2±3.0 0.852 20.2–22.4 19.9–22.6
FVC (% pred) 74.8±18.9 81.7±16.8 0.207 67.9–81.8 73.4–90.1
FEV1 (% pred) 59.1±23.5 57.2±21.3 0.786 50.4–67.7 46.6–67.8
PSQI scores (higher scores are worse)
Subjective sleep
quality
1.3±0.8 0.8±0.9 0.045
Sleep latency 1.3±1.0 1.2±0.9 0.459
Sleep duration 0.8±0.8 0.9±0.8 0.660
Habitual sleep
efficiency
0.9±1.0 0.4±0.8 0.053
Sleep disturbances 1.8±0.6 1.2±0.5 b0.001
Use of sleeping
medications
1.1±1.4 0.4±1.0 0.083
Daytime
dysfunction
1.2±0.8 0.4±0.6 0.001
Global PSQI 8.4±3.7 5.3±3.7 0.006 7.1–9.7 3.4–7.1
PSQI=Pittsburgh Sleep Quality Index.
Fig. 2. Higher reports of pain interfering with sleep are associated with worse
overall sleep quality. Each closed circle represents an individual patient and their
survey results. The BPI recorded the degree to which pain interfered with sleep
and this was correlated with the global PSQI score. Higher PSQI scores imply
worse sleep quality and a score N5 is considered abnormal.
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mean BMI was 21.3 (SD 3.0, range 17.5–28.6).
Thirty-two patients (64%) reported having had pain within the
last month. The sites of pain were varied including abdomen
(n=6), back (n=8), chest (n=3), extremities (n=2), head (n=11),
and neck (n=2). The estimate of the severity of pain (on a scale of
0–10) was generally quite severe, as seen in Fig. 1. The range of
the maximum pain was reported to be between 3 and 10.
Sleep quality was determined by the PSQI. The mean global
score for the PSQI was 7.3 (SD 4.0, range 1–15). Thirty-three
patients (66%) had an abnormal global PSQI (N5).
A comparison between patients who reported pain to those
who did not is seen in Table 1. The groups were similar in age,
nutritional status, and lung function. The patients who report
pain have a higher PSQI global score (p=0.006), which
indicates worse sleep quality in this group compared to those
without pain. The component scores are also shown in Table 1.
Patients who reported pain generally had higher scores for most
of the component scores, and were the most significant for sleep
disturbances and daytime dysfunction.
A similar analysis was made between patients based on sleep
quality comparing those with a normal global PSQI (b5) toTable 2
Comparison of patients by sleep quality.
Normal global
PSQI
Abnormal
global PSQI
p 95% Confidence
interval
n 17 33 Normal Abnormal
Age (y) 30.0±9.4 31.7±7.4 0.487 25.2–34.8 29.1–34.3
BMI 21.1±2.5 21.4±3.2 0.770 19.8–22.4 20.2–22.5
FVC (% pred) 76.1±19.2 78.1±18.1 0.719 66.2–85.9 71.6–84.6
FEV1 (% pred) 57.1±21.0 59.1±23.6 0.777 46.3–67.9 50.6–67.6
Report pain (%) 41.2 75.8 0.016 17.8–64.6 61.1–90.4those with an abnormal score (Table 2). The groups are similar
in age, nutritional status, and lung function. However, a greater
percentage of patients with an abnormal global PSQI score also
report pain, when compared to those with a normal global PSQI
score (p=0.016).
The modified BPI asked those patients who reported pain to
rate howmuch the pain interfered with sleep (on a scale of 0–10).
Those patients who did not report pain were not asked this
question, but we assumed that those patients would have
answered this question with a score of 0, which allowed us to
compare the global PSQI score with the rating of how much the
pain interfered with sleep. There was a strong positive correlation
between the global PSQI and the rating of pain interfering with
sleep (Spearman Correlation 0.56, pb0.0001). No other variables
(age, BMI, lung function) were correlated with the global PSQIFig. 3. Patients with poor sleep quality are more likely to report pain interfering
with sleep. The PSQI asks how often the subject had trouble sleeping because of
pain. This response contributes partially to the global PSQI score, but its
contribution is limited to a maximum of 1. Nonetheless, patients with impaired
sleep quality (PSQIN5) are more likely to report that pain interfered with sleep.
Fig. 4. A greater frequency of pain interfering with sleep causes worse sleep
quality. The PSQI asks how often the subject had trouble sleeping because of
pain. This response contributes partially to the global PSQI score, but its
contribution is limited to a maximum of 1. The boxplot demonstrates the median
global PSQI score, as the 10th, 25th, 75th, and 90th percentile for each group
based upon the frequency with which pain interferes with sleep. ANOVA
pb0.0001.
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of the interference of pain with sleep and the global PSQI score
can be seen in Fig. 2, where there is also a strong correlation
(pb0.001, r 2=0.32).
Those patients with an abnormal global PSQI score were
more likely to report a greater frequency of pain interfering with
their sleep when compared to those with a normal sleep quality
(Fig. 3). The patients were to report how often in the last month
that pain interfered with their sleep, with the choices of not at all
(0), less than once per week (1), once or twice per week (2), or
three or more times per week (3). There was a strong correlation
between the reported frequency of pain interfering with sleep
and the severity of abnormality of sleep quality (ANOVA
pb0.0001, Fig. 4). The significance of this analysis is due to the
differences between those patients who reported pain either 2–3
times per week or N3 times per week compared to not at all.
Finally, we found significant evidence of a logistic relation-
ship between the global PSQI score and whether or not a patient
will report experiencing pain in the last 30 days (p=0.012) with
an odds ratio of 1.27 (95% CI: 1.05–1.52).
4. Discussion
There are three important findings in this study. First, pain is
a commonly reported complaint in adults with CF and may be
reported as severe. Second, sleep quality is impaired in most
adult patients with CF. Finally, there is a strong correlation
between impaired sleep quality and self reported pain scores in
adult patients with CF.
Previous studies have demonstrated the importance of pain
in patients with CF. More than 40% of adult patients reported
pain in a recent survey [2]. The pain occurs in multiple sites
suggesting multiple etiologies, and it appears to increase in
intensity as patients have more advanced lung disease [7].However, pain is also commonly reported in children and
adolescents with CF [10] with an adverse effect on overall
quality of life. This study was not designed to describe the
epidemiology of pain in patients with CF, but our findings are
consistent with what has been reported elsewhere.
There are also several studies that have demonstrated poor
sleep quality in adults [5] and children [4,17,18] with CF.
Although the results from these studies do not always agree, a
reduction in sleep efficiency and frequent awakenings are
common findings [5,17–19]. A number of factors that can
adversely affect sleep in CF patients have been suggested
including nocturnal cough, sleep related GERD, medications,
and co-morbid sleep disordered breathing associated with nasal
polyposis [5,6,20,21], but in none of these have there been a
discussion of a role for pain.
Our finding of the association between pain and impaired
sleep quality is not surprising. A significant number of patients
with chronic pain, including patients with fibromyalgia,
scleroderma and rheumatoid arthritis, report impaired sleep
quality [12,13], Studies that have demonstrated impaired sleep
quality in other patients with chronic disease (e.g. systemic
lupus erythematosus [22], idiopathic pulmonary fibrosis [23]),
did not find an association between pain and sleep quality.
However, the patients in these studies reported pain of low
intensity and not different from control subjects; it has been
suggested that only higher levels of pain intensity interfere with
sleep quality [24].
Although we are able to demonstrate an association between
pain and impaired sleep quality, we are unable to determine a
cause and effect relationship. It is intuitive that pain adversely
affects sleep, and there are both animal and human data that
support this hypothesis. The injection of formalin into the
tibialis muscles of freely moving cats, as a model for persistent
nociception, was shown to impair sleep architecture, with a
decrease in slow wave sleep percentages, increased arousals,
and increased wakefulness implying painful symptoms acutely
alter sleep architecture [25]. Longitudinal data examining pain
and sleep quality in a fibromyalgia population reveals that pain
intensity on the day prior influences subsequent sleep quality on
the following night [26].
However, it may also be that impaired sleep quality
heightens the sensitivity to pain. The function of sleep remains
unknown but there appears to be specific analgesic properties
found in consolidated sleep. Specifically, recent well-controlled
human data shows that sleep deprivation leads to greater
daytime hyperalgesia [27,28].
5. Conclusions
We have demonstrated a strong correlation between impaired
sleep quality and pain in adult patients with CF. This finding is not
surprising given similar results from studies of other chronic
disease. However, there are important implications to these
findings. First, the assessment of pain and sleep quality should be
routine in the evaluation of adult patients with CF given the high
frequency of reported symptoms in this study. Second, both pain
and impaired sleep quality are associated with reduced quality of
325P.A. Flume et al. / Journal of Cystic Fibrosis 8 (2009) 321–325life and this represents an opportunity to improve the lives of these
patients. Third, although there may be several reasons for the
patient with CF to have impaired sleep quality (e.g. cough), the
clinician should recognize the potential role that pain may play.
Finally, therapeutic maneuvers that address both pain and sleep
architecture may be an important strategy of addressing these
symptoms. Further studies are warranted to determine whether
pain impairs sleep (or vice versa) and appropriate medications to
treat these symptoms successfully.
Acknowledgements
The authors express their great appreciation to Jonathan E.
Flume for his assistance with data collection and to Qanta
Ahmed, M.D. for her insights into sleep disorders.
References
[1] Sleep and Quality of Life in Clinical Medicine Totowa. NJ: Humana Press;
2008.
[2] Sawicki GS, Sellers DE, Robinson WM. Self-reported physical and
psychological symptom burden in adults with cystic fibrosis. J Pain
Symptom Manage 2008;35:372–80.
[3] Dobbin CJ, Bartlett D, Melehan K, Grunstein RR, Bye PT. The effect of
infective exacerbations on sleep and neurobehavioral function in cystic
fibrosis. Am J Respir Crit Care Med Jul 1 2005;172(1):99–104.
[4] Jankelowitz L, Reid KJ, Wolfe L, Cullina J, Zee PC, Jain M. Cystic fibrosis
patients have poor sleep quality despite normal sleep latency and
efficiency. Chest 2005;127(5):1593–9.
[5] Dancey DR, Tullis ED, Heslegrave R, Thornley K, Hanly PJ. Sleep quality
and daytime function in adults with cystic fibrosis and severe lung disease.
Eur J Respir Dis 2002;19(3):504–10.
[6] MilrossMA, Piper AJ, Dobbin CJ, Bye PTP, Grunstein RR. Sleep disordered
breathing in cystic fibrosis. Sleep Med Rev 2004;8(4):295–308.
[7] Ravilly S, Robinson W, Suresh S, Wohl ME, Berde CB. Chronic pain in
cystic fibrosis. Pediatrics 1996;98(4 Pt 1):741–7.
[8] QuittnerAL,BarkerDH, Snell C,GrimleyME,Marciel K,Cruz I. Prevalence
and impact of depression in cystic fibrosis. Curr Opin Pulm Med
Nov 2008;14(6):582–8.
[9] Hubbard PA, Broome ME, Antia LA. Pain, coping, and disability in
adolescents and young adults with cystic fibrosis: a web-based study. Pediatr
Nursing 2005;31(2):82–6.
[10] Palermo TM, Harrison D, Koh JL. Effect of disease-related pain on the
health-related quality of life of children and adolescents with cystic
fibrosis. Clin J Pain 2006;22(6):532–7.[11] Sayar K, Arikan M, Yontem T. Sleep quality in chronic pain patients. Can
J Psychiatry Nov 2002;47(9):844–8.
[12] Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance
in chronic pain patients. Clin J Pain Dec 1998;14(4):311–4.
[13] OhayonMM. Relationship between chronic painful physical condition and
insomnia. J Psychiatr Res Mar 2005;39(2):151–9.
[14] Cleeland CS. Measurement of pain by subjective report. In: Chapman CR,
Loeser JD, editors. Issues in pain measurement. Advances in pain research
and therapy. New York: Raven Press; 1989. p. 391–403.
[15] Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The
Pittsburgh sleep quality index: a new instrument for psychiatric practice
and research. Psych Res 1989;28(2):193–213.
[16] Milross MA, Piper AJ, Norman M, et al. Predicting sleep-disordered
breathing in patients with cystic fibrosis. Chest 2001;120(4):1239–45.
[17] Amin R, Bean J, Burklow K, Jeffries J. The relationship between sleep
disturbance and pulmonary function in stable pediatric cystic fibrosis
patients. Chest 2005;128(3):1357–63.
[18] Naqvi S, Sotelo C, Murry L, Simakajornboon N. Sleep architecture in
children and adolescents with cystic fibrosis and the association with
severity of lung disease. Sleep Breath 2008;12(1):77–83.
[19] Spier S, Rivlin J, Hughes D, Levison H. The effect of oxygen on sleep, blood
gases, and ventilation in cystic fibrosis. Am Rev Respir Dis 1984;129
(5):712–8.
[20] Stokes DC, McBride JT, Wall MA, Erba G, Strieder DJ. Sleep hypoxemia
in young adults with cystic fibrosis. Am J Dis Child 2005;134(8):741–3.
[21] Upton C. Sleep disturbance in children treated with ofloxacin. Br Med J
1994;309(6966):1411.
[22] Costa DD, Bernatsky S, Dritsa M, et al. Determinants of sleep quality in
women with systemic lupus erythematosus. Arthritis Rheum Apr 15
2005;53(2):272–8.
[23] Krishnan V, McCormack MC, Mathai SC, et al. Sleep quality and health-
related quality of life in idiopathic pulmonary fibrosis. Chest Oct 2008;134
(4):693–8.
[24] Menefee LA, Cohen MJ, Anderson WR, Doghramji K, Frank ED, Lee H.
Sleep disturbance and nonmalignant chronic pain: a comprehensive review
of the literature. Pain Med 2000;2000(1):156–72.
[25] Carli G, Montesano A, Rapezzi S, Paluffi G. Differential effects of
persistent nociceptive stimulation on sleep stages. Behav Brain Res
1987;26(2–3):89–98.
[26] Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily
relations of sleep, pain intensity, and attention to pain among women with
fibromyalgia. Pain Dec 1996;68(2–3):363–8.
[27] Onen S, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total
sleep deprivation, selective sleep interruption and sleep recovery on pain
tolerance thresholds in healthy subjects. J Sleep Res 2001;10(1):35–42.
[28] Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. Sleep loss and
REM sleep loss are hyperalgesic. Sleep Feb 1 2006;29(2):145–51.
